Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-25-006678
Filing Date
2025-03-07
Accepted
2025-03-07 16:16:15
Documents
14
Period of Report
2024-12-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A eton20250224_8ka.htm   iXBRL 8-K/A 32699
  Complete submission text file 0001437749-25-006678.txt   169936

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eton-20241219.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20241219_def.xml EX-101.DEF 11791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20241219_lab.xml EX-101.LAB 15820
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20241219_pre.xml EX-101.PRE 12006
16 EXTRACTED XBRL INSTANCE DOCUMENT eton20250224_8ka_htm.xml XML 3036
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38738 | Film No.: 25720286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)